A late-stage trial has found that Moderna's mRNA flu vaccine is more effective than the standard flu vaccine. The vaccine has been shown to outperform the standard shot, particularly in older adults, and offers immune protection against a wide array of influenza virus strains. An FDA committee has unanimously recommended the vaccine, and it has been approved by the FDA.